Fellow of The Academy of Medical Sciences, United Kingdom
Michael P. Frenneaux focuses on Internal medicine, Cardiology, Heart failure, Endocrinology and Heart disease. Many of his studies on Internal medicine apply to Anesthesia as well. His Cardiology research focuses on Diastole and how it relates to Radionuclide ventriculography.
His Heart failure research is multidisciplinary, incorporating elements of Ventricle, Placebo, QRS complex and Ranolazine. His Placebo study combines topics from a wide range of disciplines, such as Carvedilol, Bisoprolol and Metoprolol Succinate, Metoprolol. His studies in Endocrinology integrate themes in fields like Hemoglobin and Red blood cell.
The scientist’s investigation covers issues in Internal medicine, Cardiology, Heart failure, Ejection fraction and Endocrinology. His work often combines Internal medicine and In patient studies. His Cardiology study integrates concerns from other disciplines, such as Anesthesia and Diastole.
His work carried out in the field of Heart failure brings together such families of science as Ventricle, QRS complex and Perhexiline. His study in Ejection fraction focuses on Stroke volume in particular. His Hypertrophic cardiomyopathy research is multidisciplinary, relying on both Ventricular tachycardia and Sudden death.
His scientific interests lie mostly in Internal medicine, Cardiology, Heart failure, Ejection fraction and Cardiomyopathy. Michael P. Frenneaux regularly links together related areas like Endocrinology in his Internal medicine studies. His study focuses on the intersection of Cardiology and fields such as Magnetic resonance imaging with connections in the field of Pulmonary artery and Tako-tsubo Cardiomyopathy.
In his study, Hemodynamics is strongly linked to Blood pressure, which falls under the umbrella field of Heart failure. Michael P. Frenneaux usually deals with Ejection fraction and limits it to topics linked to Confidence interval and Complex disease, Ventricular vascular coupling and Meta-analysis. The concepts of his Angina study are interwoven with issues in Placebo, Crossover study, Randomized controlled trial, Surgery and Coronary artery disease.
Michael P. Frenneaux mainly investigates Internal medicine, Cardiology, Heart failure, Ejection fraction and Cardiomyopathy. His study looks at the relationship between Internal medicine and fields such as Endocrinology, as well as how they intersect with chemical problems. The various areas that he examines in his Cardiology study include Prospective cohort study, Magnetic resonance imaging and Diastole.
His Heart failure research incorporates elements of Hemodynamics, Clinical endpoint, Clinical trial and Blood pressure. Michael P. Frenneaux focuses mostly in the field of Clinical trial, narrowing it down to topics relating to Trimetazidine and, in certain cases, Placebo. Michael P. Frenneaux has included themes like Steatosis, VO2 max, Lipotoxicity, Myocardial steatosis and Blood sampling in his Ejection fraction study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)
A. Hjalmarson;S. Goldstein;B. Fagerberg;H. Wedel.
The Lancet (1999)
Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease.
Diane Fatkin;Calum MacRae;Takeshi Sasaki;Matthew R. Wolff.
The New England Journal of Medicine (1999)
Nitrate and nitrite in biology, nutrition and therapeutics
Jon O Lundberg;Mark T Gladwin;Amrita Ahluwalia;Nigel Benjamin.
Nature Chemical Biology (2009)
Metabolic Mechanisms in Heart Failure
Houman Ashrafian;Michael P. Frenneaux;Lionel H. Opie.
The Pathophysiology of Heart Failure With Normal Ejection Fraction: Exercise Echocardiography Reveals Complex Abnormalities of Both Systolic and Diastolic Ventricular Function Involving Torsion, Untwist, and Longitudinal Motion
Yu Ting Tan;Frauke Wenzelburger;Eveline Lee;Grant Heatlie.
Journal of the American College of Cardiology (2009)
Increased central pulse pressure and augmentation index in subjects with hypercholesterolemia
Ian B. Wilkinson;Krishna Prasad;Ian R. Hall;Anne Gwenllian Thomas.
Journal of the American College of Cardiology (2002)
Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy.
Brenda Gerull;Michael Gramlich;John Atherton;Mark McNabb.
Nature Genetics (2002)
Historical criteria that distinguish syncope from seizures.
Robert Sheldon;Sarah Rose;Debbie Ritchie;Stuart J. Connolly.
Journal of the American College of Cardiology (2002)
Prospective Prognostic Assessment of Blood Pressure Response During Exercise in Patients With Hypertrophic Cardiomyopathy
Nicolas Sadoul;Krishna Prasad;Perry M. Elliott;Soma Bannerjee.
Abnormal blood pressure response during exercise in hypertrophic cardiomyopathy.
M. P. Frenneaux;P. J. Counihan;A. L. P. Caforio;T. Chikamori.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: